Published reports indicate that ILK gene therapy dramatically improves cardiac function and attenuates ventricular remodeling in rat models of myocardial infarction, but it remains unknown whether, in the absence of underlying cardiac ischemia, ILK gene therapy improves cardiac performance in heart failure models [18]. This evidence concerns the gene ILK and heart failure.